nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Amitriptyline—migraine	0.0544	0.37	CbGbCtD
Epoprostenol—CYP2C9—Valproic Acid—migraine	0.0496	0.337	CbGbCtD
Epoprostenol—CYP2C9—Verapamil—migraine	0.0432	0.293	CbGbCtD
Epoprostenol—PTGIS—blood vessel—migraine	0.0168	0.149	CbGeAlD
Epoprostenol—PTGIR—blood vessel—migraine	0.00963	0.0854	CbGeAlD
Epoprostenol—PTGIS—cardiovascular system—migraine	0.00748	0.0664	CbGeAlD
Epoprostenol—P2RY12—cardiovascular system—migraine	0.00674	0.0598	CbGeAlD
Epoprostenol—PTGIR—brainstem—migraine	0.00527	0.0467	CbGeAlD
Epoprostenol—PTGIS—head—migraine	0.00507	0.0449	CbGeAlD
Epoprostenol—PTGIS—nervous system—migraine	0.0048	0.0426	CbGeAlD
Epoprostenol—PTGER1—head—migraine	0.00471	0.0418	CbGeAlD
Epoprostenol—PTGIS—central nervous system—migraine	0.00462	0.041	CbGeAlD
Epoprostenol—P2RY12—head—migraine	0.00456	0.0405	CbGeAlD
Epoprostenol—PTGER1—nervous system—migraine	0.00447	0.0396	CbGeAlD
Epoprostenol—P2RY12—nervous system—migraine	0.00432	0.0384	CbGeAlD
Epoprostenol—PTGER1—central nervous system—migraine	0.0043	0.0381	CbGeAlD
Epoprostenol—PTGIR—cardiovascular system—migraine	0.0043	0.0381	CbGeAlD
Epoprostenol—P2RY12—central nervous system—migraine	0.00416	0.0369	CbGeAlD
Epoprostenol—PTGIS—brain—migraine	0.00367	0.0326	CbGeAlD
Epoprostenol—P2RY12—brain—migraine	0.00331	0.0293	CbGeAlD
Epoprostenol—PTGIR—head—migraine	0.00291	0.0258	CbGeAlD
Epoprostenol—PTGIR—nervous system—migraine	0.00276	0.0245	CbGeAlD
Epoprostenol—PTGIR—central nervous system—migraine	0.00266	0.0236	CbGeAlD
Epoprostenol—PTGIR—cerebellum—migraine	0.0026	0.023	CbGeAlD
Epoprostenol—PTGIR—brain—migraine	0.00211	0.0187	CbGeAlD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00194	0.00752	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00192	0.00745	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.00192	0.00745	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—RAMP1—migraine	0.00187	0.00727	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CALCRL—migraine	0.00187	0.00727	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—CALCA—migraine	0.00182	0.00706	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00179	0.00693	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00178	0.00692	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00178	0.00692	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CALCRL—migraine	0.00172	0.00669	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—RAMP1—migraine	0.00172	0.00669	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—RAMP1—migraine	0.00172	0.00669	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CALCRL—migraine	0.00172	0.00669	CbGpPWpGaD
Epoprostenol—PTGIR—G alpha (s) signalling events—HTR7—migraine	0.0017	0.0066	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00166	0.00644	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00164	0.00638	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.00164	0.00638	CbGpPWpGaD
Epoprostenol—CYP2C9—cardiovascular system—migraine	0.00154	0.0136	CbGeAlD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00153	0.00593	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.00153	0.00593	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—NPS—migraine	0.00142	0.00553	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—TAC1—migraine	0.00142	0.00553	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—HTR2C—migraine	0.0014	0.00543	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—HTR1B—migraine	0.00136	0.00528	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR1D—migraine	0.00136	0.00528	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—EDNRA—migraine	0.00136	0.00528	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—HTR1A—migraine	0.00131	0.00508	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.00127	0.00495	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.00127	0.00495	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR2B—migraine	0.00126	0.00491	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00126	0.0049	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR1D—migraine	0.00125	0.00486	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HTR1D—migraine	0.00125	0.00486	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.00125	0.00485	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.00122	0.00472	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00122	0.00472	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00117	0.00456	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HTR2B—migraine	0.00116	0.00452	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR2B—migraine	0.00116	0.00452	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00116	0.00451	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.00116	0.00451	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00114	0.00443	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00112	0.00434	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00112	0.00434	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.00108	0.0042	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00108	0.00419	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.00108	0.00419	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CALCRL—migraine	0.00106	0.00411	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—RAMP1—migraine	0.00106	0.00411	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00105	0.00408	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.00105	0.00408	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.00104	0.00404	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.00103	0.00399	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.00103	0.00398	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.00103	0.00398	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.00101	0.0039	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000995	0.00387	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000995	0.00387	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000978	0.0038	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CALCRL—migraine	0.000973	0.00378	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CALCRL—migraine	0.000973	0.00378	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—RAMP1—migraine	0.000973	0.00378	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—RAMP1—migraine	0.000973	0.00378	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CALCRL—migraine	0.00096	0.00373	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—RAMP1—migraine	0.00096	0.00373	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000958	0.00372	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000958	0.00372	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000946	0.00367	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000946	0.00367	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000944	0.00366	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000944	0.00366	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000944	0.00366	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000944	0.00366	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000925	0.00359	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000925	0.00359	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.0009	0.0035	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.0009	0.0035	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—RAMP1—migraine	0.000884	0.00343	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CALCRL—migraine	0.000884	0.00343	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—RAMP1—migraine	0.000884	0.00343	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CALCRL—migraine	0.000884	0.00343	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000881	0.00342	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—HTR2A—migraine	0.000857	0.00333	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR1B—migraine	0.000824	0.0032	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000811	0.00315	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000811	0.00315	CbGpPWpGaD
Epoprostenol—Anaemia—Valproic Acid—migraine	0.000804	0.00167	CcSEcCtD
Epoprostenol—Hypersensitivity—Propranolol—migraine	0.000802	0.00166	CcSEcCtD
Epoprostenol—Mediastinal disorder—Timolol—migraine	0.000802	0.00166	CcSEcCtD
Epoprostenol—Agitation—Valproic Acid—migraine	0.0008	0.00166	CcSEcCtD
Epoprostenol—Urticaria—Verapamil—migraine	0.000796	0.00165	CcSEcCtD
Epoprostenol—Nausea—Amitriptyline—migraine	0.000794	0.00165	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—HTR1A—migraine	0.000793	0.00308	CbGpPWpGaD
Epoprostenol—Weight decreased—Topiramate—migraine	0.000788	0.00163	CcSEcCtD
Epoprostenol—Asthenia—Propranolol—migraine	0.000781	0.00162	CcSEcCtD
Epoprostenol—Pneumonia—Topiramate—migraine	0.000781	0.00162	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—TAC1—migraine	0.000781	0.00303	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—NPS—migraine	0.000781	0.00303	CbGpPWpGaD
Epoprostenol—Mental disorder—Timolol—migraine	0.00078	0.00162	CcSEcCtD
Epoprostenol—Infestation—Topiramate—migraine	0.000777	0.00161	CcSEcCtD
Epoprostenol—Infestation NOS—Topiramate—migraine	0.000777	0.00161	CcSEcCtD
Epoprostenol—Depression—Topiramate—migraine	0.000774	0.0016	CcSEcCtD
Epoprostenol—Cardiac disorder—Gabapentin—migraine	0.000769	0.00159	CcSEcCtD
Epoprostenol—Palpitations—Valproic Acid—migraine	0.000769	0.00159	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR1D—migraine	0.000768	0.00298	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000767	0.00298	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR2C—migraine	0.000766	0.00297	CbGpPWpGaD
Epoprostenol—Tension—Timolol—migraine	0.00076	0.00158	CcSEcCtD
Epoprostenol—Cough—Valproic Acid—migraine	0.000759	0.00157	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—HTR1B—migraine	0.000758	0.00294	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—HTR1B—migraine	0.000758	0.00294	CbGpPWpGaD
Epoprostenol—Urinary tract infection—Topiramate—migraine	0.000755	0.00156	CcSEcCtD
Epoprostenol—Nervousness—Timolol—migraine	0.000752	0.00156	CcSEcCtD
Epoprostenol—Mediastinal disorder—Gabapentin—migraine	0.000747	0.00155	CcSEcCtD
Epoprostenol—Diarrhoea—Propranolol—migraine	0.000745	0.00154	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—EDNRA—migraine	0.000745	0.00289	CbGpPWpGaD
Epoprostenol—Chills—Gabapentin—migraine	0.000743	0.00154	CcSEcCtD
Epoprostenol—Arthralgia—Valproic Acid—migraine	0.000741	0.00154	CcSEcCtD
Epoprostenol—Myalgia—Valproic Acid—migraine	0.000741	0.00154	CcSEcCtD
Epoprostenol—Chest pain—Valproic Acid—migraine	0.000741	0.00154	CcSEcCtD
Epoprostenol—Haematuria—Topiramate—migraine	0.00074	0.00153	CcSEcCtD
Epoprostenol—Anxiety—Valproic Acid—migraine	0.000738	0.00153	CcSEcCtD
Epoprostenol—Hypersensitivity—Verapamil—migraine	0.000738	0.00153	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000736	0.00152	CcSEcCtD
Epoprostenol—Epistaxis—Topiramate—migraine	0.000732	0.00152	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—HTR1A—migraine	0.00073	0.00283	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR1A—migraine	0.00073	0.00283	CbGpPWpGaD
Epoprostenol—Sinusitis—Topiramate—migraine	0.000729	0.00151	CcSEcCtD
Epoprostenol—Mental disorder—Gabapentin—migraine	0.000726	0.0015	CcSEcCtD
Epoprostenol—Dry mouth—Valproic Acid—migraine	0.000724	0.0015	CcSEcCtD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00072	0.0028	CbGpPWpGaD
Epoprostenol—Dizziness—Propranolol—migraine	0.00072	0.00149	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—NPS—migraine	0.000719	0.00279	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TAC1—migraine	0.000719	0.00279	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—NPS—migraine	0.000719	0.00279	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TAC1—migraine	0.000719	0.00279	CbGpPWpGaD
Epoprostenol—Asthenia—Verapamil—migraine	0.000719	0.00149	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—CALCA—migraine	0.000717	0.00278	CbGpPWpGaD
Epoprostenol—Confusional state—Valproic Acid—migraine	0.000716	0.00148	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR2B—migraine	0.000714	0.00277	CbGpPWpGaD
Epoprostenol—Flatulence—Gabapentin—migraine	0.000711	0.00147	CcSEcCtD
Epoprostenol—Anaphylactic shock—Valproic Acid—migraine	0.00071	0.00147	CcSEcCtD
Epoprostenol—Oedema—Valproic Acid—migraine	0.00071	0.00147	CcSEcCtD
Epoprostenol—Bradycardia—Topiramate—migraine	0.00071	0.00147	CcSEcCtD
Epoprostenol—Pruritus—Verapamil—migraine	0.000709	0.00147	CcSEcCtD
Epoprostenol—Tension—Gabapentin—migraine	0.000708	0.00147	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR1D—migraine	0.000707	0.00275	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR1D—migraine	0.000707	0.00275	CbGpPWpGaD
Epoprostenol—Infection—Valproic Acid—migraine	0.000705	0.00146	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—HTR2C—migraine	0.000705	0.00274	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR2C—migraine	0.000705	0.00274	CbGpPWpGaD
Epoprostenol—Haemoglobin—Topiramate—migraine	0.000701	0.00145	CcSEcCtD
Epoprostenol—Nervousness—Gabapentin—migraine	0.000701	0.00145	CcSEcCtD
Epoprostenol—Rhinitis—Topiramate—migraine	0.000699	0.00145	CcSEcCtD
Epoprostenol—Back pain—Gabapentin—migraine	0.000698	0.00145	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—HTR1D—migraine	0.000698	0.00271	CbGpPWpGaD
Epoprostenol—Haemorrhage—Topiramate—migraine	0.000697	0.00144	CcSEcCtD
Epoprostenol—Nervous system disorder—Valproic Acid—migraine	0.000696	0.00144	CcSEcCtD
Epoprostenol—Thrombocytopenia—Valproic Acid—migraine	0.000695	0.00144	CcSEcCtD
Epoprostenol—Syncope—Timolol—migraine	0.000695	0.00144	CcSEcCtD
Epoprostenol—Hypoaesthesia—Topiramate—migraine	0.000694	0.00144	CcSEcCtD
Epoprostenol—Muscle spasms—Gabapentin—migraine	0.000693	0.00144	CcSEcCtD
Epoprostenol—Tachycardia—Valproic Acid—migraine	0.000693	0.00144	CcSEcCtD
Epoprostenol—Vomiting—Propranolol—migraine	0.000692	0.00143	CcSEcCtD
Epoprostenol—Pharyngitis—Topiramate—migraine	0.000692	0.00143	CcSEcCtD
Epoprostenol—Skin disorder—Valproic Acid—migraine	0.00069	0.00143	CcSEcCtD
Epoprostenol—Oedema peripheral—Topiramate—migraine	0.000687	0.00142	CcSEcCtD
Epoprostenol—Hyperhidrosis—Valproic Acid—migraine	0.000686	0.00142	CcSEcCtD
Epoprostenol—Rash—Propranolol—migraine	0.000686	0.00142	CcSEcCtD
Epoprostenol—Dermatitis—Propranolol—migraine	0.000686	0.00142	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—EDNRA—migraine	0.000686	0.00266	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—EDNRA—migraine	0.000686	0.00266	CbGpPWpGaD
Epoprostenol—Diarrhoea—Verapamil—migraine	0.000685	0.00142	CcSEcCtD
Epoprostenol—Connective tissue disorder—Topiramate—migraine	0.000685	0.00142	CcSEcCtD
Epoprostenol—Palpitations—Timolol—migraine	0.000684	0.00142	CcSEcCtD
Epoprostenol—Loss of consciousness—Timolol—migraine	0.000681	0.00141	CcSEcCtD
Epoprostenol—Anorexia—Valproic Acid—migraine	0.000677	0.0014	CcSEcCtD
Epoprostenol—Cough—Timolol—migraine	0.000676	0.0014	CcSEcCtD
Epoprostenol—Tremor—Gabapentin—migraine	0.000676	0.0014	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—TNF—migraine	0.000674	0.00262	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—HTR7—migraine	0.000671	0.0026	CbGpPWpGaD
Epoprostenol—Anaemia—Gabapentin—migraine	0.000667	0.00138	CcSEcCtD
Epoprostenol—Hypotension—Valproic Acid—migraine	0.000664	0.00138	CcSEcCtD
Epoprostenol—Agitation—Gabapentin—migraine	0.000663	0.00137	CcSEcCtD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000663	0.00257	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000663	0.00257	CbGpPWpGaD
Epoprostenol—Dizziness—Verapamil—migraine	0.000662	0.00137	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—CALCA—migraine	0.00066	0.00256	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CALCA—migraine	0.00066	0.00256	CbGpPWpGaD
Epoprostenol—Chest pain—Timolol—migraine	0.000659	0.00137	CcSEcCtD
Epoprostenol—Myalgia—Timolol—migraine	0.000659	0.00137	CcSEcCtD
Epoprostenol—Arthralgia—Timolol—migraine	0.000659	0.00137	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR2B—migraine	0.000657	0.00255	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR2B—migraine	0.000657	0.00255	CbGpPWpGaD
Epoprostenol—Anxiety—Timolol—migraine	0.000657	0.00136	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000655	0.00136	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—HTR2B—migraine	0.000649	0.00252	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Valproic Acid—migraine	0.000647	0.00134	CcSEcCtD
Epoprostenol—Cardiac disorder—Topiramate—migraine	0.000647	0.00134	CcSEcCtD
Epoprostenol—Flushing—Topiramate—migraine	0.000647	0.00134	CcSEcCtD
Epoprostenol—Syncope—Gabapentin—migraine	0.000647	0.00134	CcSEcCtD
Epoprostenol—Nausea—Propranolol—migraine	0.000647	0.00134	CcSEcCtD
Epoprostenol—PTGIS—Metabolism—CACNA1A—migraine	0.000646	0.00251	CbGpPWpGaD
Epoprostenol—Dry mouth—Timolol—migraine	0.000645	0.00134	CcSEcCtD
Epoprostenol—Insomnia—Valproic Acid—migraine	0.000642	0.00133	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—HTR1D—migraine	0.000642	0.00249	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR1D—migraine	0.000642	0.00249	CbGpPWpGaD
Epoprostenol—Paraesthesia—Valproic Acid—migraine	0.000638	0.00132	CcSEcCtD
Epoprostenol—Palpitations—Gabapentin—migraine	0.000637	0.00132	CcSEcCtD
Epoprostenol—Confusional state—Timolol—migraine	0.000637	0.00132	CcSEcCtD
Epoprostenol—Vomiting—Verapamil—migraine	0.000637	0.00132	CcSEcCtD
Epoprostenol—Loss of consciousness—Gabapentin—migraine	0.000634	0.00131	CcSEcCtD
Epoprostenol—Dyspnoea—Valproic Acid—migraine	0.000633	0.00131	CcSEcCtD
Epoprostenol—Angiopathy—Topiramate—migraine	0.000632	0.00131	CcSEcCtD
Epoprostenol—Anaphylactic shock—Timolol—migraine	0.000632	0.00131	CcSEcCtD
Epoprostenol—Oedema—Timolol—migraine	0.000632	0.00131	CcSEcCtD
Epoprostenol—Rash—Verapamil—migraine	0.000631	0.00131	CcSEcCtD
Epoprostenol—Somnolence—Valproic Acid—migraine	0.000631	0.00131	CcSEcCtD
Epoprostenol—Dermatitis—Verapamil—migraine	0.000631	0.00131	CcSEcCtD
Epoprostenol—Cough—Gabapentin—migraine	0.000629	0.0013	CcSEcCtD
Epoprostenol—Mediastinal disorder—Topiramate—migraine	0.000628	0.0013	CcSEcCtD
Epoprostenol—Infection—Timolol—migraine	0.000628	0.0013	CcSEcCtD
Epoprostenol—Headache—Verapamil—migraine	0.000627	0.0013	CcSEcCtD
Epoprostenol—Chills—Topiramate—migraine	0.000625	0.0013	CcSEcCtD
Epoprostenol—Dyspepsia—Valproic Acid—migraine	0.000625	0.0013	CcSEcCtD
Epoprostenol—Shock—Timolol—migraine	0.000622	0.00129	CcSEcCtD
Epoprostenol—Nervous system disorder—Timolol—migraine	0.00062	0.00128	CcSEcCtD
Epoprostenol—Decreased appetite—Valproic Acid—migraine	0.000617	0.00128	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—HTR7—migraine	0.000617	0.0024	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR7—migraine	0.000617	0.0024	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000617	0.0024	CbGpPWpGaD
Epoprostenol—Chest pain—Gabapentin—migraine	0.000614	0.00127	CcSEcCtD
Epoprostenol—Myalgia—Gabapentin—migraine	0.000614	0.00127	CcSEcCtD
Epoprostenol—Arthralgia—Gabapentin—migraine	0.000614	0.00127	CcSEcCtD
Epoprostenol—Skin disorder—Timolol—migraine	0.000614	0.00127	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Valproic Acid—migraine	0.000613	0.00127	CcSEcCtD
Epoprostenol—Fatigue—Valproic Acid—migraine	0.000612	0.00127	CcSEcCtD
Epoprostenol—Anxiety—Gabapentin—migraine	0.000612	0.00127	CcSEcCtD
Epoprostenol—Hyperhidrosis—Timolol—migraine	0.000611	0.00127	CcSEcCtD
Epoprostenol—Mental disorder—Topiramate—migraine	0.000611	0.00127	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.00061	0.00126	CcSEcCtD
Epoprostenol—Constipation—Valproic Acid—migraine	0.000607	0.00126	CcSEcCtD
Epoprostenol—Pain—Valproic Acid—migraine	0.000607	0.00126	CcSEcCtD
Epoprostenol—PTGIS—Disease—LRP1—migraine	0.000606	0.00235	CbGpPWpGaD
Epoprostenol—Anorexia—Timolol—migraine	0.000603	0.00125	CcSEcCtD
Epoprostenol—Dry mouth—Gabapentin—migraine	0.000601	0.00124	CcSEcCtD
Epoprostenol—Flatulence—Topiramate—migraine	0.000598	0.00124	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—HTR2B—migraine	0.000597	0.00232	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR2B—migraine	0.000597	0.00232	CbGpPWpGaD
Epoprostenol—Tension—Topiramate—migraine	0.000595	0.00123	CcSEcCtD
Epoprostenol—Nausea—Verapamil—migraine	0.000595	0.00123	CcSEcCtD
Epoprostenol—Confusional state—Gabapentin—migraine	0.000594	0.00123	CcSEcCtD
Epoprostenol—Hypotension—Timolol—migraine	0.000591	0.00122	CcSEcCtD
Epoprostenol—Nervousness—Topiramate—migraine	0.000589	0.00122	CcSEcCtD
Epoprostenol—Anaphylactic shock—Gabapentin—migraine	0.000589	0.00122	CcSEcCtD
Epoprostenol—Oedema—Gabapentin—migraine	0.000589	0.00122	CcSEcCtD
Epoprostenol—Back pain—Topiramate—migraine	0.000587	0.00122	CcSEcCtD
Epoprostenol—Infection—Gabapentin—migraine	0.000585	0.00121	CcSEcCtD
Epoprostenol—Muscle spasms—Topiramate—migraine	0.000583	0.00121	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Valproic Acid—migraine	0.000581	0.0012	CcSEcCtD
Epoprostenol—Shock—Gabapentin—migraine	0.000579	0.0012	CcSEcCtD
Epoprostenol—Nervous system disorder—Gabapentin—migraine	0.000577	0.0012	CcSEcCtD
Epoprostenol—Thrombocytopenia—Gabapentin—migraine	0.000576	0.00119	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Timolol—migraine	0.000576	0.00119	CcSEcCtD
Epoprostenol—Tachycardia—Gabapentin—migraine	0.000575	0.00119	CcSEcCtD
Epoprostenol—Skin disorder—Gabapentin—migraine	0.000572	0.00119	CcSEcCtD
Epoprostenol—Insomnia—Timolol—migraine	0.000572	0.00118	CcSEcCtD
Epoprostenol—Hyperhidrosis—Gabapentin—migraine	0.000569	0.00118	CcSEcCtD
Epoprostenol—Tremor—Topiramate—migraine	0.000569	0.00118	CcSEcCtD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000568	0.0022	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000568	0.0022	CbGpPWpGaD
Epoprostenol—Paraesthesia—Timolol—migraine	0.000568	0.00118	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—RAMP1—migraine	0.000567	0.0022	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CALCRL—migraine	0.000567	0.0022	CbGpPWpGaD
Epoprostenol—Urticaria—Valproic Acid—migraine	0.000564	0.00117	CcSEcCtD
Epoprostenol—Dyspnoea—Timolol—migraine	0.000564	0.00117	CcSEcCtD
Epoprostenol—Somnolence—Timolol—migraine	0.000562	0.00116	CcSEcCtD
Epoprostenol—Abdominal pain—Valproic Acid—migraine	0.000561	0.00116	CcSEcCtD
Epoprostenol—Body temperature increased—Valproic Acid—migraine	0.000561	0.00116	CcSEcCtD
Epoprostenol—Anorexia—Gabapentin—migraine	0.000561	0.00116	CcSEcCtD
Epoprostenol—Anaemia—Topiramate—migraine	0.000561	0.00116	CcSEcCtD
Epoprostenol—Agitation—Topiramate—migraine	0.000558	0.00116	CcSEcCtD
Epoprostenol—Dyspepsia—Timolol—migraine	0.000556	0.00115	CcSEcCtD
Epoprostenol—Hypotension—Gabapentin—migraine	0.00055	0.00114	CcSEcCtD
Epoprostenol—Decreased appetite—Timolol—migraine	0.00055	0.00114	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Timolol—migraine	0.000546	0.00113	CcSEcCtD
Epoprostenol—Fatigue—Timolol—migraine	0.000545	0.00113	CcSEcCtD
Epoprostenol—Syncope—Topiramate—migraine	0.000544	0.00113	CcSEcCtD
Epoprostenol—Pain—Timolol—migraine	0.000541	0.00112	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Gabapentin—migraine	0.000536	0.00111	CcSEcCtD
Epoprostenol—Palpitations—Topiramate—migraine	0.000536	0.00111	CcSEcCtD
Epoprostenol—Loss of consciousness—Topiramate—migraine	0.000533	0.00111	CcSEcCtD
Epoprostenol—Insomnia—Gabapentin—migraine	0.000532	0.0011	CcSEcCtD
Epoprostenol—Cough—Topiramate—migraine	0.00053	0.0011	CcSEcCtD
Epoprostenol—Paraesthesia—Gabapentin—migraine	0.000529	0.0011	CcSEcCtD
Epoprostenol—Dyspnoea—Gabapentin—migraine	0.000525	0.00109	CcSEcCtD
Epoprostenol—Somnolence—Gabapentin—migraine	0.000523	0.00108	CcSEcCtD
Epoprostenol—Hypersensitivity—Valproic Acid—migraine	0.000523	0.00108	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—RAMP1—migraine	0.000522	0.00203	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CALCRL—migraine	0.000522	0.00203	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RAMP1—migraine	0.000522	0.00203	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CALCRL—migraine	0.000522	0.00203	CbGpPWpGaD
Epoprostenol—Dyspepsia—Gabapentin—migraine	0.000518	0.00107	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Timolol—migraine	0.000517	0.00107	CcSEcCtD
Epoprostenol—Myalgia—Topiramate—migraine	0.000517	0.00107	CcSEcCtD
Epoprostenol—Arthralgia—Topiramate—migraine	0.000517	0.00107	CcSEcCtD
Epoprostenol—Chest pain—Topiramate—migraine	0.000517	0.00107	CcSEcCtD
Epoprostenol—Anxiety—Topiramate—migraine	0.000515	0.00107	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000513	0.00106	CcSEcCtD
Epoprostenol—Decreased appetite—Gabapentin—migraine	0.000512	0.00106	CcSEcCtD
Epoprostenol—Asthenia—Valproic Acid—migraine	0.000509	0.00106	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Gabapentin—migraine	0.000508	0.00105	CcSEcCtD
Epoprostenol—Fatigue—Gabapentin—migraine	0.000508	0.00105	CcSEcCtD
Epoprostenol—Dry mouth—Topiramate—migraine	0.000505	0.00105	CcSEcCtD
Epoprostenol—Pain—Gabapentin—migraine	0.000503	0.00104	CcSEcCtD
Epoprostenol—Constipation—Gabapentin—migraine	0.000503	0.00104	CcSEcCtD
Epoprostenol—Pruritus—Valproic Acid—migraine	0.000502	0.00104	CcSEcCtD
Epoprostenol—Urticaria—Timolol—migraine	0.000502	0.00104	CcSEcCtD
Epoprostenol—Abdominal pain—Timolol—migraine	0.0005	0.00104	CcSEcCtD
Epoprostenol—Body temperature increased—Timolol—migraine	0.0005	0.00104	CcSEcCtD
Epoprostenol—Confusional state—Topiramate—migraine	0.000499	0.00103	CcSEcCtD
Epoprostenol—Oedema—Topiramate—migraine	0.000495	0.00103	CcSEcCtD
Epoprostenol—Infection—Topiramate—migraine	0.000492	0.00102	CcSEcCtD
Epoprostenol—Shock—Topiramate—migraine	0.000487	0.00101	CcSEcCtD
Epoprostenol—Diarrhoea—Valproic Acid—migraine	0.000486	0.00101	CcSEcCtD
Epoprostenol—Nervous system disorder—Topiramate—migraine	0.000486	0.00101	CcSEcCtD
Epoprostenol—Thrombocytopenia—Topiramate—migraine	0.000485	0.001	CcSEcCtD
Epoprostenol—Tachycardia—Topiramate—migraine	0.000483	0.001	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Gabapentin—migraine	0.000481	0.000998	CcSEcCtD
Epoprostenol—Skin disorder—Topiramate—migraine	0.000481	0.000997	CcSEcCtD
Epoprostenol—Hyperhidrosis—Topiramate—migraine	0.000479	0.000992	CcSEcCtD
Epoprostenol—Anorexia—Topiramate—migraine	0.000472	0.000978	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—HTR2A—migraine	0.00047	0.00182	CbGpPWpGaD
Epoprostenol—Dizziness—Valproic Acid—migraine	0.00047	0.000973	CcSEcCtD
Epoprostenol—Urticaria—Gabapentin—migraine	0.000468	0.000969	CcSEcCtD
Epoprostenol—Hypersensitivity—Timolol—migraine	0.000466	0.000965	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR1B—migraine	0.000465	0.00181	CbGpPWpGaD
Epoprostenol—Abdominal pain—Gabapentin—migraine	0.000465	0.000964	CcSEcCtD
Epoprostenol—Body temperature increased—Gabapentin—migraine	0.000465	0.000964	CcSEcCtD
Epoprostenol—Hypotension—Topiramate—migraine	0.000463	0.000959	CcSEcCtD
Epoprostenol—Asthenia—Timolol—migraine	0.000454	0.00094	CcSEcCtD
Epoprostenol—Vomiting—Valproic Acid—migraine	0.000451	0.000936	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Topiramate—migraine	0.000451	0.000935	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR1A—migraine	0.000448	0.00174	CbGpPWpGaD
Epoprostenol—Insomnia—Topiramate—migraine	0.000448	0.000928	CcSEcCtD
Epoprostenol—Rash—Valproic Acid—migraine	0.000448	0.000928	CcSEcCtD
Epoprostenol—Dermatitis—Valproic Acid—migraine	0.000447	0.000927	CcSEcCtD
Epoprostenol—Pruritus—Timolol—migraine	0.000447	0.000927	CcSEcCtD
Epoprostenol—Headache—Valproic Acid—migraine	0.000445	0.000922	CcSEcCtD
Epoprostenol—Paraesthesia—Topiramate—migraine	0.000445	0.000922	CcSEcCtD
Epoprostenol—Dyspnoea—Topiramate—migraine	0.000442	0.000915	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—TAC1—migraine	0.000441	0.00171	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—NPS—migraine	0.000441	0.00171	CbGpPWpGaD
Epoprostenol—Somnolence—Topiramate—migraine	0.00044	0.000912	CcSEcCtD
Epoprostenol—Dyspepsia—Topiramate—migraine	0.000436	0.000903	CcSEcCtD
Epoprostenol—Hypersensitivity—Gabapentin—migraine	0.000434	0.000899	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR2C—migraine	0.000433	0.00168	CbGpPWpGaD
Epoprostenol—Diarrhoea—Timolol—migraine	0.000433	0.000896	CcSEcCtD
Epoprostenol—PTGIR—GPCR ligand binding—HTR2A—migraine	0.000432	0.00168	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—HTR2A—migraine	0.000432	0.00168	CbGpPWpGaD
Epoprostenol—Decreased appetite—Topiramate—migraine	0.000431	0.000892	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR1B—migraine	0.000428	0.00166	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR1B—migraine	0.000428	0.00166	CbGpPWpGaD
Epoprostenol—Gastrointestinal disorder—Topiramate—migraine	0.000428	0.000886	CcSEcCtD
Epoprostenol—Fatigue—Topiramate—migraine	0.000427	0.000885	CcSEcCtD
Epoprostenol—Constipation—Topiramate—migraine	0.000424	0.000878	CcSEcCtD
Epoprostenol—Pain—Topiramate—migraine	0.000424	0.000878	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—HTR1B—migraine	0.000423	0.00164	CbGpPWpGaD
Epoprostenol—Asthenia—Gabapentin—migraine	0.000422	0.000875	CcSEcCtD
Epoprostenol—Nausea—Valproic Acid—migraine	0.000422	0.000874	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—EDNRA—migraine	0.000421	0.00163	CbGpPWpGaD
Epoprostenol—Dizziness—Timolol—migraine	0.000418	0.000866	CcSEcCtD
Epoprostenol—Pruritus—Gabapentin—migraine	0.000416	0.000863	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR1A—migraine	0.000412	0.0016	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR1A—migraine	0.000412	0.0016	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR1D—migraine	0.000412	0.0016	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR1A—migraine	0.000407	0.00158	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—TAC1—migraine	0.000406	0.00158	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TAC1—migraine	0.000406	0.00158	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—NPS—migraine	0.000406	0.00158	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—NPS—migraine	0.000406	0.00158	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CALCA—migraine	0.000405	0.00157	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Topiramate—migraine	0.000405	0.000839	CcSEcCtD
Epoprostenol—Diarrhoea—Gabapentin—migraine	0.000403	0.000835	CcSEcCtD
Epoprostenol—Vomiting—Timolol—migraine	0.000402	0.000833	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—TAC1—migraine	0.000401	0.00156	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—NPS—migraine	0.000401	0.00156	CbGpPWpGaD
Epoprostenol—Rash—Timolol—migraine	0.000399	0.000826	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR2C—migraine	0.000398	0.00155	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR2C—migraine	0.000398	0.00155	CbGpPWpGaD
Epoprostenol—Dermatitis—Timolol—migraine	0.000398	0.000825	CcSEcCtD
Epoprostenol—Headache—Timolol—migraine	0.000396	0.000821	CcSEcCtD
Epoprostenol—Urticaria—Topiramate—migraine	0.000393	0.000815	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—HTR2C—migraine	0.000393	0.00153	CbGpPWpGaD
Epoprostenol—Abdominal pain—Topiramate—migraine	0.000392	0.000811	CcSEcCtD
Epoprostenol—Body temperature increased—Topiramate—migraine	0.000392	0.000811	CcSEcCtD
Epoprostenol—PTGIS—Disease—CALCA—migraine	0.00039	0.00152	CbGpPWpGaD
Epoprostenol—Dizziness—Gabapentin—migraine	0.000389	0.000807	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—HTR1B—migraine	0.000389	0.00151	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR1B—migraine	0.000389	0.00151	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—EDNRA—migraine	0.000387	0.0015	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—EDNRA—migraine	0.000387	0.0015	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR2B—migraine	0.000383	0.00149	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—EDNRA—migraine	0.000382	0.00148	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR1D—migraine	0.000379	0.00147	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR1D—migraine	0.000379	0.00147	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR7—migraine	0.000379	0.00147	CbGpPWpGaD
Epoprostenol—Nausea—Timolol—migraine	0.000375	0.000778	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—HTR1A—migraine	0.000374	0.00145	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR1A—migraine	0.000374	0.00145	CbGpPWpGaD
Epoprostenol—Vomiting—Gabapentin—migraine	0.000374	0.000776	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—CALCA—migraine	0.000373	0.00145	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CALCA—migraine	0.000373	0.00145	CbGpPWpGaD
Epoprostenol—Rash—Gabapentin—migraine	0.000371	0.000769	CcSEcCtD
Epoprostenol—Dermatitis—Gabapentin—migraine	0.000371	0.000769	CcSEcCtD
Epoprostenol—Headache—Gabapentin—migraine	0.000369	0.000764	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—TAC1—migraine	0.000369	0.00143	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—NPS—migraine	0.000369	0.00143	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—NPS—migraine	0.000369	0.00143	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TAC1—migraine	0.000369	0.00143	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CALCA—migraine	0.000368	0.00143	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Topiramate—migraine	0.000365	0.000756	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—HTR2C—migraine	0.000362	0.0014	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR2C—migraine	0.000362	0.0014	CbGpPWpGaD
Epoprostenol—Asthenia—Topiramate—migraine	0.000355	0.000736	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—HTR2B—migraine	0.000353	0.00137	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2B—migraine	0.000353	0.00137	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—EDNRA—migraine	0.000352	0.00137	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—EDNRA—migraine	0.000352	0.00137	CbGpPWpGaD
Epoprostenol—Pruritus—Topiramate—migraine	0.00035	0.000726	CcSEcCtD
Epoprostenol—Nausea—Gabapentin—migraine	0.00035	0.000725	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR7—migraine	0.000349	0.00135	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR7—migraine	0.000349	0.00135	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR7—migraine	0.000344	0.00134	CbGpPWpGaD
Epoprostenol—Diarrhoea—Topiramate—migraine	0.000339	0.000702	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—CALCA—migraine	0.000339	0.00131	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CALCA—migraine	0.000339	0.00131	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—LRP1—migraine	0.000337	0.00131	CbGpPWpGaD
Epoprostenol—Dizziness—Topiramate—migraine	0.000328	0.000679	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—HTR7—migraine	0.000317	0.00123	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR7—migraine	0.000317	0.00123	CbGpPWpGaD
Epoprostenol—Vomiting—Topiramate—migraine	0.000315	0.000653	CcSEcCtD
Epoprostenol—PTGIS—Disease—TGFBR2—migraine	0.000314	0.00122	CbGpPWpGaD
Epoprostenol—Rash—Topiramate—migraine	0.000312	0.000647	CcSEcCtD
Epoprostenol—Dermatitis—Topiramate—migraine	0.000312	0.000647	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—LRP1—migraine	0.00031	0.00121	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LRP1—migraine	0.00031	0.00121	CbGpPWpGaD
Epoprostenol—Headache—Topiramate—migraine	0.00031	0.000643	CcSEcCtD
Epoprostenol—Nausea—Topiramate—migraine	0.000294	0.00061	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—HTR2A—migraine	0.000265	0.00103	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOTCH4—migraine	0.000259	0.001	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MTHFR—migraine	0.000255	0.000991	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR1B—migraine	0.00025	0.00097	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—HTR2A—migraine	0.000244	0.000949	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—HTR2A—migraine	0.000244	0.000949	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—HTR2A—migraine	0.000241	0.000936	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR1A—migraine	0.00024	0.000933	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOTCH4—migraine	0.000238	0.000925	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOTCH4—migraine	0.000238	0.000925	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PGR—migraine	0.000237	0.000919	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NPS—migraine	0.000237	0.000919	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TAC1—migraine	0.000237	0.000919	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR2C—migraine	0.000232	0.000901	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR1B—migraine	0.00023	0.000892	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR1B—migraine	0.00023	0.000892	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—EDNRA—migraine	0.000226	0.000877	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—HTR2A—migraine	0.000222	0.000861	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—HTR2A—migraine	0.000222	0.000861	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR1A—migraine	0.000221	0.000859	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR1A—migraine	0.000221	0.000859	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOTCH3—migraine	0.00022	0.000854	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PGR—migraine	0.000218	0.000846	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TAC1—migraine	0.000218	0.000846	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TAC1—migraine	0.000218	0.000846	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PGR—migraine	0.000218	0.000846	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPS—migraine	0.000218	0.000846	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPS—migraine	0.000218	0.000846	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CALCA—migraine	0.000217	0.000844	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—MTHFR—migraine	0.000214	0.00083	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2C—migraine	0.000214	0.00083	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR2C—migraine	0.000214	0.00083	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—EDNRA—migraine	0.000208	0.000807	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—EDNRA—migraine	0.000208	0.000807	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR7—migraine	0.000203	0.000789	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOTCH3—migraine	0.000203	0.000786	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOTCH3—migraine	0.000203	0.000786	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CALCA—migraine	0.0002	0.000777	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CALCA—migraine	0.0002	0.000777	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR7—migraine	0.000187	0.000727	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR7—migraine	0.000187	0.000727	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFBR2—migraine	0.000175	0.00068	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFBR2—migraine	0.000161	0.000626	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFBR2—migraine	0.000161	0.000626	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—HTR2A—migraine	0.000142	0.000553	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR2A—migraine	0.000131	0.000509	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2A—migraine	0.000131	0.000509	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ESR1—migraine	0.000126	0.000491	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ESR1—migraine	0.000116	0.000452	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ESR1—migraine	0.000116	0.000452	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CACNA1A—migraine	0.000104	0.000406	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—migraine	3.46e-05	0.000134	CbGpPWpGaD
